UK trial assessing AZ’ AZD1775 in head and neck cancer
A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with…
ViiV trials long-acting, two-drug HIV regimen
ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in…
AZ teams up with G1 on lung cancer combination therapy
AstraZeneca has signed a deal with US group G1 Therapeutics to test the potential of a new combination therapy for…
WIRB-Copernicus Group Partners with Veeva Systems Inc to improve the speed and accuracy of institutional review board (IRB) document transfer
WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today…
Bayer/Nektar experimental inhaled antibiotic fails in Phase III
Bayer and Nektar Therapeutics’ experimental inhaled antibiotic has failed to hit key targets assessing its effect on survival in patients…
Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced that GSK, a world leader in respiratory,…
Bevacizumab leads clinical trial activity for monoclonal antibodies, says GlobalData
When tracking clinical trial activity across the world, GlobalData, a leading data and analytics company, identified 5,273 industry monoclonal antibodies…
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high…
SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer
SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase…